Amedeo Smart

Free Medical Literature Service

 

Amedeo

Asthma
  Free Subscription

Articles published in
Pulm Pharmacol Ther
    December 2023
  1. WANG J, Jian Q, Yan K, Yang J, et al
    m(6)A-modified miR-143-3p inhibits epithelial mesenchymal transition in bronchial epithelial cells and extracellular matrix production in lung fibroblasts by targeting Smad3.
    Pulm Pharmacol Ther. 2023;83:102251.
    >> Share

    November 2023
  2. DEBOWSKI T, Marko M, Rogala B, Majak P, et al
    Improvement of asthma control in adult patients using extrafine inhaled beclomethasone/formoterol fixed combination as maintenance therapy as well as maintenance and reliever therapy - control study.
    Pulm Pharmacol Ther. 2023 Nov 28:102272. doi: 10.1016/j.pupt.2023.102272.
    >> Share

  3. DRAGONIERI S, Quaranta VN, Portacci A, Carpagnano GE, et al
    Can single-inhaler Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium therapy postpone or save biologics for severe asthma?
    Pulm Pharmacol Ther. 2023;83:102270.
    >> Share

    October 2023
  4. ROGLIANI P, Radovanovic D, Ora J, Starc N, et al
    Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol.
    Pulm Pharmacol Ther. 2023;82:102231.
    >> Share

    April 2023
  5. TAKEDA Y, Takahashi M, Fuchikami JI, Nakamura H, et al
    Effect of roflumilast on airway remodeling in asthmatic mice exposed to or not exposed to cigarette smoke: Comparison with the effect of dexamethasone.
    Pulm Pharmacol Ther. 2023;79:102198.
    >> Share

    January 2023
  6. ZHANG P, Jia Y, Jing Z, Huang J, et al
    Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma.
    Pulm Pharmacol Ther. 2023 Jan 2:102187. doi: 10.1016/j.pupt.2022.102187.
    >> Share

    December 2022
  7. MA S, Yang K, Li Z, Li L, et al
    A retro-inverso modified peptide alleviated ovalbumin-induced asthma model by affecting glycerophospholipid and purine metabolism of immune cells.
    Pulm Pharmacol Ther. 2022;78:102185.
    >> Share

  8. O'BYRNE PM, Panettieri RA Jr, Taube C, Brindicci C, et al
    Development of an inhaled anti-TSLP therapy for asthma.
    Pulm Pharmacol Ther. 2022;78:102184.
    >> Share

  9. XU J, Yang L, Lin T
    beta-sitosterol targets glucocorticoid receptor to reduce airway inflammation and remodeling in allergic asthma.
    Pulm Pharmacol Ther. 2022 Dec 5:102183. doi: 10.1016/j.pupt.2022.102183.
    >> Share

  10. DAVIS BE, Cockcroft DW
    Effect of daily dosing with tiotropium against methacholine induced bronchoconstriction in asthmatics.
    Pulm Pharmacol Ther. 2022;77:102174.
    >> Share

  11. BRATTSAND R, Selroos O
    May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?
    Pulm Pharmacol Ther. 2022;77:102167.
    >> Share

    October 2022
  12. GUO YL, Chen ZC, Li N, Tian CJ, et al
    SRSF1 promotes ASMC proliferation in asthma by competitively binding CCND2 with miRNA-135a.
    Pulm Pharmacol Ther. 2022 Oct 21:102173. doi: 10.1016/j.pupt.2022.102173.
    >> Share

    August 2022
  13. CHEN H, Kunder R, Zou Y, Staton T, et al
    Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation.
    Pulm Pharmacol Ther. 2022;75:102133.
    >> Share

    July 2022
  14. TSUBOKAWA D, Satoh M
    Strongyloides venezuelensis-derived venestatin ameliorates asthma pathogenesis by suppressing receptor for advanced glycation end-products-mediated signaling.
    Pulm Pharmacol Ther. 2022 Jul 18:102148. doi: 10.1016/j.pupt.2022.102148.
    >> Share

    June 2022
  15. NAGASE H, Tamaoki J, Suzuki T, Nezu Y, et al
    Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan.
    Pulm Pharmacol Ther. 2022 Jun 14:102130. doi: 10.1016/j.pupt.2022.102130.
    >> Share

    April 2022
  16. BUHL R, Nikolaev I, Tillmann HC, Vaidya S, et al
    Corrigendum to "Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma" [Pulm. Pharmacol. Therapeut. 70 (2021)
    Pulm Pharmacol Ther. 2022 Apr 11:102126. doi: 10.1016/j.pupt.2022.102126.
    >> Share

    March 2022
  17. CALZETTA L, Pistocchini E, Cito G, Ritondo BL, et al
    Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma.
    Pulm Pharmacol Ther. 2022 Mar 26:102125. doi: 10.1016/j.pupt.2022.102125.
    >> Share

    December 2021
  18. ZORAMPARI C, Prakash A, Rehan HS, Gupta LK, et al
    Serum dipeptidyl peptidase-4 and eosinophil cationic protein levels in patients of bronchial asthma.
    Pulm Pharmacol Ther. 2021 Dec 31:102109. doi: 10.1016/j.pupt.2021.102109.
    >> Share

  19. ZHU R, Owen R, Wilkins J, Schoemaker R, et al
    Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps.
    Pulm Pharmacol Ther. 2021;71:102080.
    >> Share

  20. ROSSI V, Salimaki J, Sandler C, Airaksinen M, et al
    Effectiveness of inhalation technique assessment service for patients with Respimat(R) inhaler.
    Pulm Pharmacol Ther. 2021;71:102077.
    >> Share

    October 2021
  21. SUTTON SS, Magagnoli J, Cummings TH, Hardin JW, et al
    Leukotriene Inhibition and the Risk of Lung Cancer among U.S. Veterans with Asthma.
    Pulm Pharmacol Ther. 2021 Oct 15:102084. doi: 10.1016/j.pupt.2021.102084.
    >> Share

  22. ALIDA B, Stefania P, Noemi CM, Maria I, et al
    Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: tips for facing the second wave.
    Pulm Pharmacol Ther. 2021 Oct 7:102083. doi: 10.1016/j.pupt.2021.102083.
    >> Share

  23. VAIDYA S, Ziegler D, Tanase AM, Malmqvist U, et al
    Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers.
    Pulm Pharmacol Ther. 2021;70:102019.
    >> Share

    August 2021
  24. LUO Y, Chen H, Huang R, Wu Q, et al
    Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-kappaB signals in OVA-induced asthmatic mice.
    Pulm Pharmacol Ther. 2021;69:102049.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016